Various - Specialized “Combat Cancer” Tribute To The Clash flac album

The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

Various ‎– SPECIALIZED COMBAT CANCER Tribute To THE CLASH NEW CLEAR 7" VINYL.

Various - Specialized Combat Cancer Tribute To The Clash FLAC version. 1509 downloads at 17 mb/s. Various - Specialized Combat Cancer Tribute To The Clash MP3 version. 1464 downloads at 13 mb/s.

A1 –Gigantor, Lynval Golding. I Fought The Law. A2 –Horace Panter, Rat Scabies, Neil Innes, Kevin Eldon Tommy Gun. B1 –The Pressure Tenants. B2 –Nick Welsh, Susan Cadogan. Written-By – The Clash. Benefit release by The Specialized Project for the Teenage Cancer Trust in the.

Every penny,every nickle,every dime, every quarter and dollar will help in finding a cure for this nasty word we call "cancer" For those of you who are thinking of donating it's never too late. an Dorston Combat Cancer TeamPosts.

A cancer treatment known as "immunotherapy" has the potential to revolutionise the way we treat/manage malignant diseases. It involves programming the immune system to attack and remove cancer cells from anywhere in the body. It's at an early stage but some people with life-threatening cancers have been cured by the technique

When these particles hit cancer cells, they damage their DNA, which in the best case leads to killing off the neoplastic cells. Compared to X-ray irradiation, the ions discharge their destructive energy only, if they fall short of a certain speed when piercing through tissue. This is a huge advantage, because tissue that is pierced prior to undercutting that speed is hardly damaged and also the tissue behind the tumour remains largely free of radiation. We reckon that in future five to ten per cent of all cancer patients will profit from radiation therapy with ions or protons", says Jürgen Debus, Scientific and Medical Director of the HIT.